Claude Petit

Learn More
OBJECTIVE Experience of pain in major depressive disorder (MDD) can complicate diagnosis and impair treatment outcomes. This study evaluated the efficacy and safety of duloxetine in the treatment of patients with moderate pain associated with depression. METHOD In this double-blind, placebo-controlled, 8-week study, conducted from May 2005 to May 2006,(More)
OBJECTIVES This post hoc analysis compared how patients and physicians estimate disease severity and global improvement during 8 weeks of treatment for major depressive disorder (MDD) with associated nonspecific pain. In addition, predictors of pain and depression were identified. METHOD Data were derived from a double-blind, placebo-controlled,(More)
  • 1